Cargando…

Experiences of people with opioid use disorder during the COVID-19 pandemic: A qualitative study

AIM: To capture pandemic experiences of people with opioid use disorder (OUD) to better inform the programs that serve them. DESIGN: We designed, conducted, and analyzed semi-structured qualitative interviews using grounded theory. We conducted interviews until theme saturation was reached and we it...

Descripción completa

Detalles Bibliográficos
Autores principales: Galarneau, Lexis R., Hilburt, Jesse, O’Neill, Zoe R., Buxton, Jane A., Scheuermeyer, Frank X., Dong, Kathryn, Kaczorowski, Janusz, Orkin, Aaron M., Barbic, Skye Pamela, Bath, Misty, Moe, Jessica, Miles, Isabelle, Tobin, Dianne, Grier, Sherry, Garrod, Emma, Kestler, Andrew
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8320992/
https://www.ncbi.nlm.nih.gov/pubmed/34324589
http://dx.doi.org/10.1371/journal.pone.0255396
_version_ 1783730745715458048
author Galarneau, Lexis R.
Hilburt, Jesse
O’Neill, Zoe R.
Buxton, Jane A.
Scheuermeyer, Frank X.
Dong, Kathryn
Kaczorowski, Janusz
Orkin, Aaron M.
Barbic, Skye Pamela
Bath, Misty
Moe, Jessica
Miles, Isabelle
Tobin, Dianne
Grier, Sherry
Garrod, Emma
Kestler, Andrew
author_facet Galarneau, Lexis R.
Hilburt, Jesse
O’Neill, Zoe R.
Buxton, Jane A.
Scheuermeyer, Frank X.
Dong, Kathryn
Kaczorowski, Janusz
Orkin, Aaron M.
Barbic, Skye Pamela
Bath, Misty
Moe, Jessica
Miles, Isabelle
Tobin, Dianne
Grier, Sherry
Garrod, Emma
Kestler, Andrew
author_sort Galarneau, Lexis R.
collection PubMed
description AIM: To capture pandemic experiences of people with opioid use disorder (OUD) to better inform the programs that serve them. DESIGN: We designed, conducted, and analyzed semi-structured qualitative interviews using grounded theory. We conducted interviews until theme saturation was reached and we iteratively developed a codebook of emerging themes. Individuals with lived experience of substance use provided feedback at all steps of the study. SETTING: We conducted phone or in-person interviews in compliance with physical distancing and public health regulations in outdoor Vancouver parks or well-ventilated indoor spaces between June to September 2020. PARTICIPANTS: Using purposive sampling, we recruited participants (n = 19) who were individuals with OUD enrolled in an intensive community outreach program, had visited one of two emergency departments, were over 18, lived within catchment, and were not already receiving opioid agonist therapy. MEASUREMENTS: We audio-recorded interviews, which were later transcribed verbatim and checked for accuracy while removing all identifiers. Interviews explored participants’ knowledge of COVID-19 and related safety measures, changes to drug use and healthcare services, and community impacts of COVID-19. RESULTS: One third of participants were women, approximately two thirds had stable housing, and ages ranged between 23 and 59 years old. Participants were knowledgeable on COVID-19 public health measures. Some participants noted that fear decreased social connection and reluctance to help reverse overdoses; others expressed pride in community cohesion during crisis. Several participants mentioned decreased access to housing, harm reduction, and medical care services. Several participants reported using drugs alone more frequently, consuming different or fewer drugs because of supply shortages, or using more drugs to replace lost activities. CONCLUSION: COVID-19 had profound effects on the social lives, access to services, and risk-taking behaviour of people with opioid use disorder. Pandemic public health measures must include risk mitigation strategies to maintain access to critical opioid-related services.
format Online
Article
Text
id pubmed-8320992
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-83209922021-07-31 Experiences of people with opioid use disorder during the COVID-19 pandemic: A qualitative study Galarneau, Lexis R. Hilburt, Jesse O’Neill, Zoe R. Buxton, Jane A. Scheuermeyer, Frank X. Dong, Kathryn Kaczorowski, Janusz Orkin, Aaron M. Barbic, Skye Pamela Bath, Misty Moe, Jessica Miles, Isabelle Tobin, Dianne Grier, Sherry Garrod, Emma Kestler, Andrew PLoS One Research Article AIM: To capture pandemic experiences of people with opioid use disorder (OUD) to better inform the programs that serve them. DESIGN: We designed, conducted, and analyzed semi-structured qualitative interviews using grounded theory. We conducted interviews until theme saturation was reached and we iteratively developed a codebook of emerging themes. Individuals with lived experience of substance use provided feedback at all steps of the study. SETTING: We conducted phone or in-person interviews in compliance with physical distancing and public health regulations in outdoor Vancouver parks or well-ventilated indoor spaces between June to September 2020. PARTICIPANTS: Using purposive sampling, we recruited participants (n = 19) who were individuals with OUD enrolled in an intensive community outreach program, had visited one of two emergency departments, were over 18, lived within catchment, and were not already receiving opioid agonist therapy. MEASUREMENTS: We audio-recorded interviews, which were later transcribed verbatim and checked for accuracy while removing all identifiers. Interviews explored participants’ knowledge of COVID-19 and related safety measures, changes to drug use and healthcare services, and community impacts of COVID-19. RESULTS: One third of participants were women, approximately two thirds had stable housing, and ages ranged between 23 and 59 years old. Participants were knowledgeable on COVID-19 public health measures. Some participants noted that fear decreased social connection and reluctance to help reverse overdoses; others expressed pride in community cohesion during crisis. Several participants mentioned decreased access to housing, harm reduction, and medical care services. Several participants reported using drugs alone more frequently, consuming different or fewer drugs because of supply shortages, or using more drugs to replace lost activities. CONCLUSION: COVID-19 had profound effects on the social lives, access to services, and risk-taking behaviour of people with opioid use disorder. Pandemic public health measures must include risk mitigation strategies to maintain access to critical opioid-related services. Public Library of Science 2021-07-29 /pmc/articles/PMC8320992/ /pubmed/34324589 http://dx.doi.org/10.1371/journal.pone.0255396 Text en © 2021 Galarneau et al https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
Galarneau, Lexis R.
Hilburt, Jesse
O’Neill, Zoe R.
Buxton, Jane A.
Scheuermeyer, Frank X.
Dong, Kathryn
Kaczorowski, Janusz
Orkin, Aaron M.
Barbic, Skye Pamela
Bath, Misty
Moe, Jessica
Miles, Isabelle
Tobin, Dianne
Grier, Sherry
Garrod, Emma
Kestler, Andrew
Experiences of people with opioid use disorder during the COVID-19 pandemic: A qualitative study
title Experiences of people with opioid use disorder during the COVID-19 pandemic: A qualitative study
title_full Experiences of people with opioid use disorder during the COVID-19 pandemic: A qualitative study
title_fullStr Experiences of people with opioid use disorder during the COVID-19 pandemic: A qualitative study
title_full_unstemmed Experiences of people with opioid use disorder during the COVID-19 pandemic: A qualitative study
title_short Experiences of people with opioid use disorder during the COVID-19 pandemic: A qualitative study
title_sort experiences of people with opioid use disorder during the covid-19 pandemic: a qualitative study
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8320992/
https://www.ncbi.nlm.nih.gov/pubmed/34324589
http://dx.doi.org/10.1371/journal.pone.0255396
work_keys_str_mv AT galarneaulexisr experiencesofpeoplewithopioidusedisorderduringthecovid19pandemicaqualitativestudy
AT hilburtjesse experiencesofpeoplewithopioidusedisorderduringthecovid19pandemicaqualitativestudy
AT oneillzoer experiencesofpeoplewithopioidusedisorderduringthecovid19pandemicaqualitativestudy
AT buxtonjanea experiencesofpeoplewithopioidusedisorderduringthecovid19pandemicaqualitativestudy
AT scheuermeyerfrankx experiencesofpeoplewithopioidusedisorderduringthecovid19pandemicaqualitativestudy
AT dongkathryn experiencesofpeoplewithopioidusedisorderduringthecovid19pandemicaqualitativestudy
AT kaczorowskijanusz experiencesofpeoplewithopioidusedisorderduringthecovid19pandemicaqualitativestudy
AT orkinaaronm experiencesofpeoplewithopioidusedisorderduringthecovid19pandemicaqualitativestudy
AT barbicskyepamela experiencesofpeoplewithopioidusedisorderduringthecovid19pandemicaqualitativestudy
AT bathmisty experiencesofpeoplewithopioidusedisorderduringthecovid19pandemicaqualitativestudy
AT moejessica experiencesofpeoplewithopioidusedisorderduringthecovid19pandemicaqualitativestudy
AT milesisabelle experiencesofpeoplewithopioidusedisorderduringthecovid19pandemicaqualitativestudy
AT tobindianne experiencesofpeoplewithopioidusedisorderduringthecovid19pandemicaqualitativestudy
AT griersherry experiencesofpeoplewithopioidusedisorderduringthecovid19pandemicaqualitativestudy
AT garrodemma experiencesofpeoplewithopioidusedisorderduringthecovid19pandemicaqualitativestudy
AT kestlerandrew experiencesofpeoplewithopioidusedisorderduringthecovid19pandemicaqualitativestudy